KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) Research & Development: 2012-2024

Historic Research & Development for CareDx (CDNA) over the last 13 years, with Dec 2024 value amounting to $72.4 million.

  • CareDx's Research & Development fell 4.10% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.6 million, marking a year-over-year decrease of 7.45%. This contributed to the annual value of $72.4 million for FY2024, which is 11.56% down from last year.
  • CareDx's Research & Development amounted to $72.4 million in FY2024, which was down 11.56% from $81.9 million recorded in FY2023.
  • In the past 5 years, CareDx's Research & Development ranged from a high of $90.4 million in FY2022 and a low of $48.9 million during FY2020.
  • Over the past 3 years, CareDx's median Research & Development value was $81.9 million (recorded in 2023), while the average stood at $81.6 million.
  • Its Research & Development has fluctuated over the past 5 years, first spiked by 59.36% in 2020, then fell by 11.56% in 2024.
  • Yearly analysis of 5 years shows CareDx's Research & Development stood at $48.9 million in 2020, then spiked by 56.36% to $76.5 million in 2021, then rose by 18.12% to $90.4 million in 2022, then declined by 9.43% to $81.9 million in 2023, then dropped by 11.56% to $72.4 million in 2024.